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Epigenetically Altered Wound Healing in Keloid
Fibroblasts
Shirley B. Russell1,2, James D. Russell3,9, Kathryn M. Trupin3,9, Angela E. Gayden4, Susan R. Opalenik5,
Lillian B. Nanney6, Alan H. Broquist1, Latha Raju7 and Scott M. Williams8
Keloids are benign dermal tumors that form during wound healing in genetically susceptible individuals. The
mechanism(s) of keloid formation is unknown and there is no satisfactory treatment. We have reported
differences between fibroblasts cultured from normal scars and keloids that include a pattern of glucocorticoid
resistance and altered regulation of genes in several signaling pathways associated with fibrosis, including Wnt
and IGF/IGF-binding protein 5 (IGFBP5). As previously reported for glucocorticoid resistance, decreased expression of
the Wnt inhibitor secreted frizzled-related protein 1 (SFRP1), matrix metalloproteinase 3 (MMP3), and dermatopontin
(DPT), and increased expression of IGFBP5 and jagged 1 (JAG1) are seen only in fibroblasts cultured from the keloid
nodule. In vivo, decreased expression of SFRP1 and SFRP2 and increased expression of IGFBP5 proteins are observed
only in proliferative keloid tissue. There is no consistent difference in the replicative life span of normal and keloid
fibroblasts, and the altered response to hydrocortisone (HC) and differential regulation of a subset of genes in
standard culture medium are maintained throughout at least 80% of the culture lifetime. Preliminary studies using
ChIP–chip analysis, Trichostatin A, and 5-aza-20-deoxycytidine further support an epigenetically altered program in
keloid fibroblasts that includes an altered pattern of DNA methylation and histone acetylation.
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INTRODUCTION
Keloids are fibrotic tumors of the dermis that form during a
protracted wound-healing process. The predisposition to
form keloids is found predominantly in people of African,
Asian, and Hispanic descent (Niessen et al., 1999; Butler
et al., 2008). Keloids occur in B1 in 30 African Americans
and B1 in 625 of the overall US population (Barrett, 1973).
Although this disfiguring and sometimes disabling disorder of
wound healing significantly impairs the quality of life, it is
understudied relative to other chronic skin disorders
(Bock et al., 2006). The key alteration(s) responsible for the
pathological process has not been identified and, as for
other fibrotic disorders, there is no satisfactory treatment
(Niessen et al., 1999; Lupher and Gallatin, 2006; Butler et al.,
2008). Moreover, keloid formation is one of a group of
fibroproliferative diseases characterized by an exaggerated
response to injury that occur at higher frequency or with
more severe manifestations in people of African ancestry
(Smith et al., 2008). We have reported differences in
expression of a broad spectrum of wound-healing-related
genes between normal and keloid fibroblasts under standard
culture conditions in medium containing 10% fetal bovine
serum (Russell et al., 1995; Meyer et al., 2000; Smith et al.,
2008). We have also reported a pattern of differences
in growth and synthesis of extracellular matrix induced by
several regulators of wound healing. These include an altered
growth response to hydrocortisone (HC) (Russell et al., 1978)
and resistance of keloid fibroblasts to HC downregulation of
types I, III and V collagen, elastin, connective tissue growth
factor (CTGF), and IGF-binding protein 3 (IGFBP3) gene
expression (Russell et al., 1978, 1989, 1995; Smith et al.,
2008). HC resistance is observed only in fibroblasts from the
keloid nodule; fibroblasts cultured from superficial dermis of
keloids and from unaffected dermis of keloid patients behave
like normal skin and scar fibroblasts. These findings suggest
that fibroblasts from the keloid nodule are distinct from other
dermal fibroblasts in the affected individual. Although some
cases of keloid formation may be due to somatic mutation
(Saed et al., 1998), multiple keloids in the same individual
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and evidence for a multicellular origin of keloids (Chevray
and Manson, 2004) argue against somatic mutation as the
primary event and suggest that an environmental factor
present during wound healing triggers abnormal gene
expression in genetically susceptible individuals. Various
studies have implicated keratinocytes, Langerhans cells,
mast cells, and T cells in skin fibrosis (Niessen et al., 1999;
Phan et al., 2003; Butler et al., 2008). Thus, differences in
gene expression in keloid fibroblasts may be due to either
expression of the abnormal gene(s) by the fibroblasts
themselves, or expression by another cell type, causing
selection of an epigenetically distinct subpopulation of
fibroblasts in normal skin.
Since first described (Hayflick and Moorhead, 1961), it
has been well established that human diploid fibroblasts
show a limited proliferative life span followed by replicative
senescence (Cristofalo et al., 2004). Effects of cellular
aging on gene expression have been reported, including
increased expression of matrix metalloproteinase (MMP) 1
and 3, plasminogen activator inhibitor and cyclin-dependent
kinase inhibitors, and both increased and decreased collagen
synthesis (Zeng et al., 1996; Cristofalo et al., 2004;
Ravelojaona et al., 2008). Decreased responsiveness to HC
during in vitro cellular aging has also been reported
(Cristofalo and Rosner, 1979). Because fibroblasts in keloids
may have undergone more population doublings during
tumor formation than normal dermis or scar fibroblasts, we
investigated whether normal and keloid cultures differ in their
in vitro proliferative capacity, and whether the different
pattern of gene expression in normal and keloid fibroblasts is
stable throughout the in vitro lifetime, or as normal fibroblasts
age they adopt the gene expression pattern of keloid
fibroblasts. A stable pattern over the in vitro lifetime and
similar growth capacity of normal and keloid fibroblasts
would refute the view that the altered program in keloid
fibroblasts is due to increased cellular age and would support
the hypothesis that keloid fibroblasts represent an epigeneti-
cally distinct population of fibroblasts selected during wound
healing in individuals predisposed to form keloids.
RESULTS
Differential expression of a subset of fibrosis-associated genes in
keloid fibroblasts is seen only in cultures from the keloid nodule
(lesion)
Having previously observed that the pattern of glucocorticoid
resistance of keloid fibroblasts to downregulation of elastin
and collagen is confined to the keloid nodule, we determined
whether differential expression of other genes in our gene
expression profiling study was confined to fibroblasts
from the lesion. We used quantitative real-time PCR to
measure levels of expression in cultures from an abdominal
keloid, superficial dermis of the same lesion, and normal
abdominal skin excised at the same time as the keloid
(Russell et al., 1978).
In the gene profiling studies we observed significantly
increased expression of IGFBP5, jagged 1 (JAG1), and CTGF,
and decreased expression of secreted frizzled-related protein
1 (SFRP1), MMP3, and dermatopontin (DPT) in keloid
fibroblasts (Smith et al., 2008). As seen in Table 1, altered
expression is observed only in cultures from the lesion.
Differences in expression in fibroblasts from the lesion
compared to superficial dermis or nearby normal skin were
similar to those previously seen when fibroblasts from keloid
lesions were compared with normal scars from unaffected
individuals. The only exception was that CTGF was
expressed at higher levels in fibroblasts from the keloid
lesion in the presence and absence of HC, although the
increase was greater in its presence. Immunohistochemical
examination revealed decreased SFRP1 and SFRP2 (Figure 1a
and b) and increased IGFBP5 protein (Figure 1c) only in
Table 1. Differential expression of a subset of
fibrosis-related genes is observed only in fibroblasts
cultured from the keloid nodule
Hydrocortisone +Hydrocortisone
Gene
symbol
Nodule/
superficial
dermis
Nodule/
normal
dermis
Nodule/
superficial
dermis
Nodule/
normal
dermis
SFRP1 0.0003 0.0004 0.009 0.001
MMP3 0.0002 0.0009 0.009 0.023
DPT 0.002 0.001 0.006 0.002
IGFBP5 6.32 11.79 70.03 43.41
JAG1 55.71 36.76 17.39 8.94
CTGF 4.41 4.41 10.06 7.26
a b
c
Figure 1. Distribution of SFRP1, SFRP2, and IGFBP5 immunostaining in
keloid tissue. (a) Active fibroblasts (left of dotted line) show no SFRP1 staining;
inactive fibroblasts (right of dotted line) show positive staining. (b) Active
fibroblasts (left of dotted line) show minimal SFRP2 staining; inactive fibroblasts
(right of dotted line) show positive staining. Only keloid tissue left of dotted lines
in a and b stains for type 1 procollagen, a marker of activated fibroblasts (data
not shown). (c) Robust IGFBP5 immunoreactivity is seen only in area left of
dotted line, which contains numerous elongated fibroblasts that appear to be
actively growing and migrating. Weakly stained fibroblasts right of dotted line
show a rounded more mature phenotype and are sparsely distributed in matrix.
Insets on lower left and upper right show high-magnification field of each area.
Scale bars for a and b ¼ 100mm; c ¼ 500mm.
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active areas of keloid tissue. Expression in inactive areas did
not differ from that observed in normal dermis from
unaffected individuals (data not shown).
Do differences in cell age account for gene expression
differences?
To determine whether differential patterns of gene expression
reflect the greater age of keloid cells that may have
undergone more population doublings during tumor forma-
tion, we assessed differences in proliferative potential and
whether normal cells aged in vitro adopt an expression
pattern similar to that of keloid cultures.
Included in our collection of fibroblasts are two strains
each of normal (21 and 130) and keloid (33 and 50)
fibroblasts that were cultured to senescence in the presence
and absence of 1.5 mM HC and preserved in liquid nitrogen at
different in vitro culture ages ranging from approximately
44 to 5 population doublings from senescence. These
cultures would be roughly equivalent to passage numbers
1–22, assuming two doublings per passage. Because the
number of generations undergone before establishing in vitro
cultures cannot be accurately assessed, culture age is
expressed as generations from senescence or, where several
strains are averaged, the approximate percentage of in vitro
lifetime.
Proliferative histories of the four fibroblast strains are
depicted in Figure 2a–d. Age-related changes in growth
characteristics were similar for all strains and were unaffected
by continuous growth in HC (data not shown). Maximum
cell density decreased in a roughly linear manner throughout
the culture lifetime whereas population doubling time
remained relatively constant until approximately 10 genera-
tions before senescence and then increased in an accelerating
manner.
The total number of population doublings for each strain
cultured with and without HC is summarized in Supplementary
Table S1 online. Keloid strain 50 underwent fewer population
doublings than the other strains; however, keloid strain 33 did
not differ significantly in total population doublings from cells
derived from normal skin or normal mature scar.
Differential responses to HC and altered expression of fibrosis-
associated genes in keloid fibroblasts grown in standard culture
medium are maintained over the culture lifetime
We previously reported that growth of early passage
fibroblasts in 1.5 mM HC increased the maximum cell density
of normal fibroblasts but lowered or had no effect on the
maximum density of fibroblasts from keloid lesions (Russell
et al., 1978). When the effect of HC was examined in normal
strain 21 at different generations from senescence, the
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Figure 2. Proliferative history of two normal and two keloid strains and effect of in vitro aging on HC-mediated growth stimulation of normal fibroblasts.
Each cell culture was initiated from the previous cycle on day indicated. Cell counts are averages of duplicate cultures and expressed as log2 of cell number
so that each unit equals one population doubling. (a) Normal strain 130; (b) normal strain 21; (c) keloid strain 33; (d) keloid strain 50; (e) effect of HC on
maximum cell density of strain 21 during the fourth culture cycle before a change in growth rate; (f) effect of HC on maximum cell density of strain 21 during
the seventh culture cycle after the growth rate change. Control (circles); HC (triangles).
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differential effect of HC persisted as maximum cell density
decreased linearly over the culture lifetime (Figure 2 e and f).
Although we observed no differences in rate of collagen
synthesis between multiple strains of normal and keloid
fibroblasts grown in standard culture medium, we have
reported a differential effect of 1.5 mM HC on percent collagen
synthesis, mRNA levels for types I, III, and V collagen and
prolyl hydroxylase activity (Russell et al., 1978, 1989; Trupin
et al., 1983).
To determine whether the rate of collagen synthesis
changes and whether the differential effect of HC is
maintained throughout the culture lifetime, we estimated
percent collagen synthesis from rates of incorporation of
3H-proline into collagen and noncollagen proteins (Russell
et al., 1978) at different generations from senescence. We
observed little change in percent collagen synthesis as a
function of cellular aging (Table 2), and the differential effect
of HC on collagen synthesis in normal versus keloid fibro-
blasts was maintained throughout most of the culture lifetime.
To further examine the effect of cellular aging on the HC
response, we used quantitative real-time PCR to measure
expression of a1(I) collagen, elastin, and CTGF genes in cell
strains 21 and 33 grown with 0.28mM ascorbic acid with and
without HC. As seen in Table 2, HC downregulated the
expression of all three genes in normal fibroblasts over many
cell generations, but had little effect on collagen gene
expression in keloid fibroblasts, and increased expression of
elastin and CTGF.
To determine the effect of cellular aging on several
additional genes whose differential expression was seen only
in fibroblasts from the keloid nodule, we compared normal
strains 21 and 130 to keloid strains 33 and 50 at three in vitro
ages, approximately 16, 59, and 79% of the culture lifetime
(Table 3). We observed that decreased expression of SFRP1
and MMP3, and increased expression of IGFBP5 and JAG1 in
keloid fibroblasts were maintained for many cell generations.
Silencing of SFRP1 is not due to hypermethylation in keloid
fibroblasts; increased SFRP1 expression in response to
Trichostatin A is consistent with a role for decreased histone
acetylation in keloid fibroblasts
Epigenetic silencing of tumor promoters by hypermethylation
and differential histone acetylation, including those of
multiple SFRPs, often occurs in early stages of tumorigenesis
(Suzuki et al., 2002; Jones and Baylin, 2007; Kawamoto et al.,
2008). However, analysis of the SFRP1 promoter from 20
keloid and 10 normal strains using the Sequenom MassAR-
RAY System failed to show detectable methylation in either
cell type (data not shown). Although preliminary genome-
wide ChIP–chip assay of pooled DNA samples revealed
differential methylation of multiple genes in keloid versus
normal fibroblasts, it did not show differential methylation of
the SFRP1 gene (see Supplementary Figure S1 online).
Hypermethylation of genes in the homeotic (HOX)A cluster
correlated with decreased expression of HOXA9 and
HOXA10 in keloid cells. Hypomethylation of the asporin,
thrombin-like receptor, and MMP3 promoters in the keloid
sample also correlated with differential gene expression;
asporin and the thrombin-like receptor are overexpressed
whereas MMP3 is underexpressed (Smith et al., 2008).
Preliminary experiments using 1-day treatment with
0.33 mM Trichostatin A (TSA), an inhibitor of histone
deacetylation and 4-day treatment with 2 mM 5-aza-20-
deoxycytidine (5-aza-dC), an inhibitor of DNA methylation,
revealed that expression of SFRP1 in keloid fibroblasts was
increased almost 15-fold by TSA but not by 5-aza-dC
(Table 4). TSA, but not 5-aza-dC, decreased expression of
JAG1 whereas both TSA and 5-aza-dC decreased IGFBP5
expression more in keloid than in normal cells. HOXA10
expression was undetectable in keloid fibroblasts in the
absence of inhibitors but was increased by both TSA and
5-aza-dC. Both inhibitors decreased expression of collagen
and CTGF to a similar extent in normal and keloid fibroblasts.
Experiments on two additional normal and keloid strains
confirmed that TSA selectively increases expression of SFRP1
and decreases expression of IGFBP5 and JAG1 in keloid but
not in normal cells (data not shown).
DISCUSSION
We previously reported that an altered growth response to
HC and resistance of keloid fibroblasts to HC downregulation
of collagen and elastin are observed only in fibroblasts from
the keloid nodule, findings that support the hypothesis that
keloid fibroblasts are an epigenetically distinct subpopulation
(Russell et al., 1978, 1989, 1995). Here we provide further
evidence for that hypothesis. The differential expression of
several fibrosis-associated genes, including the Wnt inhibitor
SFRP1, MMP3, DPT, JAG1, CTGF, and IGFBP5, is confined to
fibroblasts cultured from the keloid nodule. Immunohisto-
chemical measurements confirmed that decreased levels of
SFRP1 and SFRP2 and increased levels of IGFBP5 are
confined to active keloid tissue.
The hypothesis that differences between normal and
keloid fibroblasts in culture are due to differences in vivo
aging is not supported by our studies. Although the number of
in vitro population doublings may not accurately reflect the
number of divisions undergone in vivo (Cristofalo et al.,
2004; Maier and Westendorp, 2009), detailed analysis of the
replicative life span of two keloid and two normal strains
aged in the presence or absence of HC revealed no consistent
differences to support the hypothesis that fibroblasts cultured
from keloids underwent more population doublings than
fibroblasts from normal dermis or scar in the formation of the
tumor. HC has been reported to extend (Cristofalo and
Rosner, 1979) or have no effect (Didinsky and Rheinwald,
1981) on the replicative life span of normal fibroblasts. We
observed little effect of HC on the life span of either normal or
keloid fibroblasts.
It is routine to compare patterns of gene expression in
cultured cells at low passage number to minimize loss of an
in vivo phenotype (Feghali and Wright, 1999; Smith et al.,
2008; Tuan et al., 2008). It has been reported that simply
culturing cells results in loss of a difference in a1b1 integrin
collagen receptor expression between fibroblasts from
keloids and normal skin (Szulgit et al., 2002). However,
some characteristics of an altered program are retained for
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many generations in culture. An example is the persistent
downregulation of Fli1, a suppressor of collagen transcrip-
tion, in scleroderma fibroblasts in vivo and in vitro
(Wang et al., 2006; Asano et al., 2007). We have found that
the altered pattern of gene expression in keloid fibroblasts,
including failure of HC to downregulate collagen, elastin,
and CTGF, decreased expression of SFRP1 and MMP3, and
increased expression of IGFBP5 and JAG1 in standard culture
medium is not abolished for at least 80% of the replicative
life span. Although not identifying a mechanism, these
findings support the hypothesis of an epigenetically regulated
program of fibrosis. Furthermore, persistence of the stimula-
tory effect of HC on growth of normal fibroblasts throughout
the culture lifetime contradicts the notion that as normal
fibroblasts age they act like keloid fibroblasts.
Recent inhibitor studies have provided evidence that
epigenetic alterations occur during activation of wound
healing and fibrosis. TSA blocks transforming growth factor
b-mediated myofibroblastic differentiation (Glenisson et al.,
2007) and induction of collagen gene expression (Rombouts
et al., 2002; Ghosh et al., 2007) in human skin fibroblasts.
TSA also prevents accumulation of extracellular matrix in a
mouse model of bleomycin-induced skin fibrosis (Huber
et al., 2007). TSA and 5-aza-dC have been reported to
reverse epigenetic repression of the Fli1 gene and to decrease
collagen expression in scleroderma fibroblasts (Wang et al.,
2006). Gene profiling studies have revealed no differences in
expression of Fli1 in keloid fibroblasts; thus Fli1 does not
appear to be involved in the keloid program of fibrosis.
The findings of our study support an altered program of
DNA methylation and histone acetylation that could account
for the stable pattern of differential gene expression in keloid
fibroblasts in culture. These epigenetically distinct fibroblasts
may have been produced or selected in the wound-healing
environment of genetically predisposed individuals. Although
not irreversible, patterns of DNA methylation and histone
modifications can be replicated over many cell generations
in vivo and in vitro by complex albeit incompletely under-
stood mechanisms involving chromatin architecture, long-
range gene interactions, and a complex network of trans-
acting proteins and noncoding RNAs (Margueron and
Reinberg, 2010). The observation that TSA-induced reversal
of SFRP1 gene silencing is associated with decreased
expression of profibrotic IGFBP5 and JAG1 supports a role
for differential histone acetylation of the SFRP1 gene or of a
gene(s) that regulates SFRP1 expression in keloids. SFRP1 is
best known as an inhibitor of Wnt signaling and increased
Wnt signaling has been reported to be involved in the
pathogenesis of keloids (Sato, 2006) and several other fibrotic
disorders including pulmonary and renal fibrosis (Morrisey,
2003; He et al., 2009). SFRP1 and SFRP2 have recently been
reported to inhibit bone morphogenetic protein signaling
(Misra and Matise, 2010). Increased BMP signaling has been
implicated in fibrotic disorders such as fibrodysplasia
ossificans progressiva (Kaplan et al., 2009). Therefore,
silencing of SFRP1 may be important in the fibrosis signature
shown by keloid fibroblasts. Although these inhibitor studies
do not identify causal relationships between the expression of
different genes, they provide additional evidence for an
epigenetically altered program in keloid fibroblasts. This
program may be further elucidated by determining individual
gene and genome-wide patterns of DNA methylation
Table 2. Resistance of keloid fibroblasts to HC
downregulation of a subset of matrix and matrix-
related genes is maintained during in vitro aging
Percent collagen synthesis
Cell strain
Generations
from
senescence Control +HC HC/control
Differential effect of HC on percent collagen synthesis
Normal 21 39 15 3.6 0.24
34 9.5 2 0.21
29 11.4 3.2 0.28
24 10.5 3.2 0.30
17 11.8 3 0.25
14 11.4 2.3 0.20
10 9.5 3.6 0.38
6 6.8 7.7 1.13
Normal 130 48 8 2 0.25
40 8.2 2.7 0.33
31 8.2 3 0.37
25 8.9 3.9 0.44
16 9 5 0.56
Keloid 33 38 9.1 5 0.55
27 7.3 4.5 0.62
24 8.6 6 0.70
20 8.6 7 0.81
13 10.9 7 0.64
7 10.7 8.9 0.83
Keloid 50 25 17.7 16.4 0.93
18 20 17.3 0.87
11 20 18.4 0.92
7 22 19.5 0.89
Cell strain
Generations
from
senescence
Type I
collagen
HC/control
Elastin
HC/
control
CTGF
HC/
control
Differential effect of HC on expression of type I collagen, elastin, and
CTGF genes
Normal 21 38 0.23 0.09 0.31
26 0.19 0.08 0.54
15 0.25 0.04 0.26
Keloid 33 37 0.76 2.09 5.79
25 0.93 2.70 3.17
11 1.05 1.52 1.87
Abbreviation: HC, hydrocortisone.
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and histone modification. Manipulation of expression of
specific epigenetically modified genes may identify causal
relationships. Characterization of an epigenetically altered
program in cultured fibroblasts may reveal mechanisms
leading to keloid formation and suggest strategies to treat or
prevent keloids and possibly other fibrotic disorders that
disproportionately affect individuals of African ancestry.
MATERIALS AND METHODS
Cell culture
Methods of isolation and propagation of fibroblasts from keloids,
normal dermis, and scars have been described (Russell et al., 1978;
Smith et al., 2008). Sources of cell strains, all of which were
obtained from African-American patients, have been presented
(Russell et al., 1978; Trupin et al., 1983; Smith et al., 2008). Cultures
are grown at 37 1C in an atmosphere of air and CO2 adjusted to
maintain a pH of 7.4 with 100% humidity. The culture medium
consists of 90% F-10 (Sigma, St Louis, MO) and 10% fetal bovine
serum (Invitrogen, Grand Island, NY). No antibiotics or antimycotics
are used so that culture dishes inadvertently subjected to bacterial
or fungal contamination may be quickly detected, thus minimizing
spread of infection to other dishes and avoiding antibiotic selection
for mycoplasma. Cells are subcultured using 0.025% trypsin
(Invitrogen) and 0.004% NaEDTA. Cell counts for initiating
experimental cultures and for quantitating cell growth are carried
out using a Coulter Counter Z1 (Beckman Coulter, Brea, CA).
Cultures are preserved in liquid nitrogen using a programmable
freezer (Planer Products, Sudbury on Thames, UK). Institutional
review boards at Vanderbilt University, Tennessee Valley Health
Care System, and Meharry Medical College have approved
all described studies. The study was conducted according to the
Declaration of Helsinki Principles.
Quantitative real-time PCR
Total RNA is isolated using an RNeasy Mini Kit (Qiagen, Valencia,
CA) and reverse-transcribed using a cDNA Archive kit (Applied
Biosystems, Foster City, CA). Assays are performed using an iQ
real-time PCR system (Bio-Rad Laboratories, Hercules, CA). Specific
gene expression is measured as described (Smith et al., 2008).
Fold-differences in expression of selected genes are estimated using
the comparative CT method described in User Bulletin no. 2 ABI
PRISM 7700 Sequence Detection System (Applied Biosystems, 2001).
Fold difference ranges are determined by evaluating the expression:
2DDCT ± s, where s is the standard deviation of DDCT.
Immunohistochemistry
Standard immunohistochemical procedures available in Vanderbilt’s
Immunohistochemistry Core Laboratory were modified where
necessary for particular protein probes. For tissue sections, keloids
were fixed in paraformaldehyde for 24 hours, embedded in paraffin,
and sectioned at 5mm. Sections were immunostained with rabbit
polyclonal antibodies directed against IGFBP5 (Upstate Biotechno-
logy, Lake Placid, NY), SFRP1 (Abcam, Cambridge, MA), and SFRP2
(Sigma). Antigen retrieval methods were used as needed.
Table 3. Altered expression of a subset of fibrosis-related genes is maintained in keloid fibroblasts during in vitro
aging
Keloid/normal (range) n=2, n=2 Keloid/normal (range) n=2, n=2
Average percent in vitro lifetime ± SD 16±5 59±6 79±9
SFRP1 0.009 (0.001–0.067) 0.005 (0.001–0.025) 0.003 (0.002–0.003)
MMP3 0.05 (0.02–0.10) 0.013 (0.003–0.050) 0.009 (0.008–0.009)
IGFBP5 10.06 (8.03–12.62) 12.40 (12.19–12–60) 8.07 (5.55–11.76)
JAG1 7.64 (1.56–37.18) 63.27 (30.35–131.60) 9.50 (0.81–112.19)
Table 4. Effect of TSA and 5-aza-dC on gene expression in keloid and normal fibroblasts
Gene symbol Normal TSA/control Keloid TSA/control Normal 5-aza-dC/control Keloid 5-aza-dC/control
SFRP1 1.26 14.59 0.42 0.57
SFRP2 0.33 0.25 0.06 0.34
DKK3 0.83 0.41 0.23 0.14
HOXA10 0.59 mm 0.13 mm
MMP3 0.64 0.87 0.56 0.52
IGFBP5 0.60 0.08 0.74 0.09
JAG1 0.16 0.03 0.17 0.16
COL1A1+HC 0.44 0.41 0.11 0.23
CTGF+HC 0.43 0.55 0.17 0.23
Abbreviations: 5-aza-dC, 5-aza-20-deoxycytidine; TSA, Trichostatin A.
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DNA methylation analysis
Methylation was quantified using the SequenomMassARRAY System
(Sequenom, Newton, MA). Genomic DNA was isolated from
fibroblasts and bisulfite treated to convert nonmethylated cytosines
to uracils (C to T in PCR amplification products). These C/T
variations appear as G/A variations in cleavage products generated
from the reverse strand by base-specific cleavage. The G/A variations
result in a mass difference of 16Da per CpG site, detectable by the
MassARRAY system. Relative amount of methylation was calculated
by comparing the signal intensity between the mass signals of
methylated and nonmethylated templates. PCR primers, selected to
hybridize with sequences that do not contain CpG, are designed
to yield amplification products of between 200 and 600 bases. In the
case of the SFRP1 CpG island, six amplicons were sufficient to
provide overlapping coverage of the entire island.
Methylated DNA immunoprecipitation (MeDIP) and
microarray
Pooled DNA from normal and keloid strains used in gene profiling
studies was digested with Mse1 to produce small fragments
(200–1,000bp) while keeping CpG islands intact, denatured, and
subjected to methylated DNA immunoprecipitation (MeDIP). Ampli-
fied ChIP samples were labeled with different fluorophores and co-
hybridized to a NimbleGen CpG-Island Plus promoter array (Roche
NimbleGen, Madison, WI). A computer program developed to analyze
data from NimbleGen-tiled microarrays (ACME) was used to identify
signals or ‘‘peaks’’ in the array data using a simple sliding window and
threshold strategy. A probability value was assigned to each probe on
the array (Scacheri et al., 2006). Peak files (.gff) identifying regions of
DNA methylation were generated from the P-value files, and peaks
were mapped to the transcription start site of each gene and visualized
using SignalMap, a software package provided by NimbleGen.
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